PRED MILD, 0.12% recall — Abbvie Inc. (Class III)

Abbvie Inc. is recorded by the U.S. Food and Drug Administration (FDA) as recalling PRED MILD, 0.12% — a Class III recall, initiated 2026-05-18 and posted to the FDA enforcement report on 2026-06-03, under recall number D-0551-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Failed Stability Specifications”. From the product description, the form is ophthalmic suspension, the strengths given are 0.12% and 10 mL and it is marked Rx only. 1 National Drug Code number is printed in the record: 11980-174-10. Distribution is recorded as “US Nationwide” — Nationwide (US), with the recalling firm on record in IL, United States. It is the only recall number the FDA has filed under event ID 99008. 16 days separate the firm's initiation date from the FDA's report date on this record. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0551-2026
FDA event ID 99008
Classification Class III (least serious regulatory tier)
Status Ongoing
Recalling firm Abbvie Inc.
Recall initiated 2026-05-18
Reported by FDA 2026-06-03
Report lag 16 days from initiation to report
Distribution US Nationwide. — Nationwide (US)
Firm location on record IL, United States
Product description (source) PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.

Reason reported by FDA

Failed Stability Specifications

3 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

6 identifying values matched by exact pattern in the 27-word product description above; each is a literal substring of it.

Product named PRED MILD
Form Ophthalmic Suspension
Strength 0.12% · 10 mL
NDC 11980-174-10
Marketing category Rx only
Stated origin France

Reported in the same month (2026-06)

74 enforcement reports carry a report date in 2026-06; these 5 are the Class III ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Nicotine Transdermal System Patch, 14 mgD-0550-2026Aveva Drug Delivery Systems, Inc.Class III2026-06-03
Lidocaine HCl Injection, 2%D-0552-2026Eugia US LLCClass III2026-06-10
Epinephrine Injection, 1mg/mLD-0581-2026Fresenius Kabi Usa, LLCClass III2026-06-17
Primidone Tablets, 50 mgD-0585-2026Amneal Pharmaceuticals, LLCClass III2026-06-17
Focalin XR (dexmethylphenidate HCl) 5 mgD-0608-2026Sandoz IncClass III2026-06-24

Nearest Class III recalls by date

25 of 250 indexed records share the Class III tier; the 10 nearest to 2026-06-03 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Primidone Tablets USP, 250mgD-0533-2026Lannett Company Inc.250mg · Tablets2026-05-27
Primidone Tablets, 50 mgD-0534-2026Golden State Medical Supply Inc.50 mg · Tablets2026-05-27
Primidone Tablets, 250 mgD-0535-2026Golden State Medical Supply Inc.250 mg · Tablets2026-05-27
Primidone Tablets, 250 mgD-0536-2026Amerisource Health Services LLC250 mg · Tablets2026-05-27
Primidone Tablets, 50 mgD-0537-2026Amerisource Health Services LLC50 mg · Tablets2026-05-27
Busulfan Injection, 60 mgD-0539-2026Sagent Pharmaceuticals60 mg · Injection2026-05-27
busPIRone Hydrochloride Tablets, 5 mgD-0511-2026Unichem Pharmaceuticals Usa Inc.5 mg · Tablets2026-05-13
Levocarnitine Injection, 1 g/5 mLD-0494-2026American Regent, Inc.1 g/5 mL · Injection2026-05-06
Lidocaine Wound Gel, 0.13%D-0509-2026Water-jel Technologies, LLC0.13% · Gel2026-05-06
hydrOXYzine Hydrochloride Oral Solution, 10 mg/5 mLD-0619-2026Ani Pharmaceuticals, Inc.10 mg/5 mL · Oral Solution2026-07-01

Reading this record

Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 11980-174-10 at the FDA source to confirm it is covered.

Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Abbvie Inc. (1 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0551-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0551-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-06-03
Ingested
2026-08-22
Record hash
447eb961a0eb2d25

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.